Related Experiment Video
Updated: Jul 26, 2025

10:53
Plaque Assay for Murine Norovirus
Published on: August 22, 2012
54.8K
Effect of Norovirus Inoculum Dose on Virus Kinetics, Shedding, and Symptoms
Emerging Infectious Diseases
|June 22, 2023
Summary
Higher norovirus doses accelerate virus shedding and symptom onset in humans. The study suggests increased norovirus dose may lead to more severe illness, though virus load effects were inconclusive.
Area of Science:
- Virology
- Infectious Diseases
- Epidemiology
Background:
- The relationship between norovirus dose and infection outcomes remains unclear.
- Understanding dose-response is crucial for norovirus infection control and prevention strategies.
Purpose of the Study:
- To investigate the impact of varying norovirus doses on viral shedding and symptom development.
- To analyze dose-dependent effects on the timing and severity of norovirus infection.
Main Methods:
- Secondary analysis of a human norovirus challenge study.
- Application of Bayesian mixed-effects models to assess dose-response relationships.
- Quantification of viral shedding in feces and vomit using reverse transcription PCR (RT-PCR).
Main Results:
- Increased norovirus dose correlated with decreased onset time for fecal viral shedding (1.4 to 0.8 days).
- Higher doses led to earlier peak viral shedding (2.3 to 1.5 days) and faster symptom onset (1.5 to 0.8 days).
- A trend towards increased symptom severity was observed with higher norovirus doses, though virus load effects were inconclusive.
Conclusions:
- Norovirus dose significantly influences the kinetics of viral shedding and symptom onset.
- Higher infectious doses may result in more rapid and potentially more severe norovirus infections.
- Further research is needed to definitively establish the dose-load relationship in norovirus infections.

